Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)

Table 2 Binary logistic regression analysis on 50%MHD Responder Rate in CM

	B	S.E.	Wald	Significance	Odds ratio	95% C.I.
	B	S.E.	Wald	Significance	Odds ratio	Lower	Upper
Age	.026	.021	1.473	.225	1.026	.984	1.070
Sex	.155	.574	.073	.787	1.168	.379	3.599
BMI	−.107	.051	4.429	.035	.899	.814	.993
Failed preventive treatments	−.266	.114	5.420	.020	.766	.612	.959

ISSN: 1129-2377